Drug class

Nitrosoureas

Nitrosoureas are a distinct class of lipophilic alkylating antineoplastic agents that exert cytotoxic effects by alkylating and cross-linking DNA, thereby inhibiting nucleic acid synthesis and cell division. Read more about Nitrosoureas

18 drugs in this class 16 manufacturers

Advertisement

Drugs in Nitrosoureas

Showing 10–18 of 18 drugs

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
ATHENEX PHARMAC

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
MEITHEAL PHARMA

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
NOVADOZ PHARMAC

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
SANDOZ

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
Avet Pharmaceuticals

CARMUSTINE

NITROSOUREAS · MALIGNANT BRAIN NEOPLASM ·+6
AVET-NOVAPLUS

LOMUSTINE

NITROSOUREAS · HODGKIN'S LYMPHOMA ·+1
CARNEGIE PHARMA
Filter & compare in the drug finder → Opens the drug finder with Nitrosoureas preselected. Add indication or manufacturer filters there.

About Nitrosoureas.

Nitrosoureas are a distinct class of lipophilic alkylating antineoplastic agents that exert cytotoxic effects by alkylating and cross-linking DNA, thereby inhibiting nucleic acid synthesis and cell division.

Due to their marked lipid solubility, agents such as carmustine and lomustine readily cross the blood-brain barrier, making them clinically important therapies for central nervous system malignancies, including high-grade gliomas and brain metastases.

They are also utilized, often in combination regimens, to treat lymphomas, multiple myeloma, and, in the case of streptozocin, pancreatic neuroendocrine islet cell tumors.